PharmaShots | Incisive News in 3 Shots

Subscribe Now

Gracell Biotechnologies

Gracell Biotechnologies Reports the US FDA Clearance of IND Application for GC012F to Treat Multiple Myeloma

Gracell Biotechnologies Reports the US FDA Clearance of IND Application for GC012F to Treat Multiple Myeloma

January 30, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us